Infusystem(INFU)2020-04-01 21:55
$Infusystem(INFU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001014108-20-000047 Size: 10 KB 网页链接
| 今开：17.5 | 昨收：17.5 |
| 最高：17.79 | 最低：17.4 |
| 涨停价： | 跌停价： |
| 总市值：359003174 |
Infusystem(INFU)2020-04-01 21:55
$Infusystem(INFU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001014108-20-000047 Size: 10 KB 网页链接
Infusystem(INFU)2020-04-03 05:10
$Infusystem(INFU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001014108-20-000048 Size: 7 KB 网页链接
Infusystem(INFU)2020-03-19 18:40
$Infusystem(INFU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-20-005616 Act: 34 Size: 337 KB 网页链接
Infusystem(INFU)2020-03-31 02:50
$Infusystem(INFU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001014108-20-000046 Size: 7 KB 网页链接
Infusystem(INFU)2020-04-01 06:10
$Infusystem(INFU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001445866-20-000310 Size: 11 KB 网页链接
Infusystem(INFU)2020-04-09 21:15
$Infusystem(INFU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-20-007378 Act: 34 Size: 2 MB 网页链接
Infusystem(INFU)2020-04-04 00:55
$Infusystem(INFU)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-20-007080 Act: 34 Size: 1 MB 网页链接
Infusystem(INFU)2020-03-30 18:15
$Infusystem(INFU)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-20-006370 Act: 34 Size: 9 MB 网页链接
Infusystem(INFU)2020-02-11 07:00
$Infusystem(INFU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001014108-20-000011 Size: 6 KB 网页链接
Infusystem(INFU)2020-03-31 08:46
$Infusystem(INFU)$ 内部交易: 2020-03-26,总裁 and CEO,Dilorio Richard ,买入,1000普通股, $7.99
Infusystem(INFU)01-08 07:34
$Infusystem(INFU)$ 内部交易: 2021-01-05,总裁 & CEO,Dilorio Richard ,期权,60000普通股, $0.00查看全文
Infusystem(INFU)01-08 07:34
$Infusystem(INFU)$ 内部交易: 2021-12-31,VP and Corporate Controller,Whitman Kevin ,期权,3000普通股, $0.00查看全文
Infusystem(INFU)01-08 05:27
$Infusystem(INFU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001014108-21-000003 Size: 8 KB 网页链接查看全文
Infusystem(INFU)01-08 04:42
$Infusystem(INFU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001014108-21-000002 Size: 9 KB 网页链接查看全文
Infusystem(INFU)2020-12-15 19:42
$Infusystem(INFU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-20-025330 Act: 34 Size: 51 KB 网页链接查看全文
Infusystem(INFU)2020-12-15 05:42
$Infusystem(INFU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-20-025299 Act: 34 Size: 38 KB 网页链接查看全文
Infusystem(INFU)2020-12-11 05:42
$Infusystem(INFU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-20-025112 Act: 34 Size: 39 KB 网页链接查看全文
Infusystem(INFU)2020-12-10 07:33
$Infusystem(INFU)$ 内部交易: 2020-12-09,Director,BlueLine Capital Partners II, ,卖出,1705普通股, $17.00查看全文
Infusystem(INFU)2020-12-10 07:33
$Infusystem(INFU)$ 内部交易: 2020-12-08,Director,BlueLine Capital Partners II, ,卖出,4489普通股, $17.04查看全文
Infusystem(INFU)2020-12-10 07:33
$Infusystem(INFU)$ 内部交易: 2020-12-07,Director,BlueLine Capital Partners II, ,卖出,2900普通股, $17.21查看全文
8月14日Infusystem(股票代码：INFU)公布财报，公告显示公司2018财年中报净利润为-30.10万美元，同比增长88.35%；营业收入为3289.80万美元，同比下跌4.91%。InfusystemHoldings ... 网页链接
8月14日Infusystem(股票代码：INFU)公布财报，公告显示公司2018财年第二财季净利润为-50.50万美元，同比增长54.34%；营业收入为1641.50万美元，同比下跌3.11%。InfusystemHoldin ... 网页链接
4月24日Infusystem(股票代码：INFU)公布财报，公告显示公司2018财年第一财季净利润为20.40万美元，同比增长113.8%；营业收入为1648.30万美元，同比下跌6.63%。 InfusystemHoldings ... 网页链接
3月13日Infusystem(股票代码：INFU)公布财报，公告显示公司2017财年第四财季净利润为-1799.40万美元，同比下降3704.23%；营业收入为1889.30万美元，同比上涨12.1%。 InfusystemHol ... 网页链接
$Infusystem(INFU)$ 内部交易: 2021-01-05,总裁 & CEO,Dilorio Richard ,期权,60000普通股, $0.00
$Infusystem(INFU)$ 内部交易: 2021-12-31,VP and Corporate Controller,Whitman Kevin ,期权,3000普通股, $0.00
$Infusystem(INFU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001014108-21-000003 Size: 8 KB 网页链接
$Infusystem(INFU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001014108-21-000002 Size: 9 KB 网页链接
$Infusystem(INFU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-20-025330 Act: 34 Size: 51 KB 网页链接
$Infusystem(INFU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-20-025299 Act: 34 Size: 38 KB 网页链接
$Infusystem(INFU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-20-025112 Act: 34 Size: 39 KB 网页链接
$Infusystem(INFU)$ 内部交易: 2020-12-09,Director,BlueLine Capital Partners II, ,卖出,1705普通股, $17.00
$Infusystem(INFU)$ 内部交易: 2020-12-08,Director,BlueLine Capital Partners II, ,卖出,4489普通股, $17.04
$Infusystem(INFU)$ 内部交易: 2020-12-07,Director,BlueLine Capital Partners II, ,卖出,2900普通股, $17.21